UB Paderborn / Katalog / Suche / in CDI

Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2014-01, Vol.17 (1), p.188-195

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract 5414: The correlation between the expression of microRNA hsa-miR-101 and the prognosis of the patient with hepatocellular carcinoma

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.5414-5414

2018

Link zum Volltext

Verfügbarkeit prüfen

Degraded DNA may induce discordance of KRAS status between primary colorectal cancer and corresponding liver metastases

International journal of clinical oncology, 2014-02, Vol.19 (1), p.113-120

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4444: MicroRNA hsa-miR-145 expression in hepatocellular carcinoma correlates with patient survival

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.4444-4444

2017

Link zum Volltext

Verfügbarkeit prüfen

Drug monitoring during FOLFOX6 therapy in a rectal cancer patient on chronic hemodialysis

Japanese journal of clinical oncology, 2010-04, Vol.40 (4), p.360-364

2010

Link zum Volltext

Verfügbarkeit prüfen

Simple index for validity of the evaluation point for dosimetric verification results of intensity-modulated radiation therapy using a Farmer-type ionization chamber

Journal of X-ray science and technology, 2018-01, Vol.26 (3), p.473

2018

Link zum Volltext

Verfügbarkeit prüfen

Association of insulin-like growth factor binding protein-3 expression with melanoma progression

Molecular cancer therapeutics, 2006-12, Vol.5 (12), p.3078-3084

2006

Link zum Volltext

Verfügbarkeit prüfen

When should anti-cancer treatment be ended? Why and when to discontinue palliative chemotherapy

Journal of clinical oncology, 2018-12, Vol.36 (34_suppl), p.41-41

2018

Link zum Volltext

Verfügbarkeit prüfen

Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are Associated with Chemoresponse to S-1 in Colon Cancer

Cancer genomics & proteomics, 2006-10, Vol.3 (5), p.317-324

2006

Link zum Volltext

Verfügbarkeit prüfen

Multi-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancer

BMC genomics, 2006-04, Vol.7 (1), p.68-68, Article 68

2006

Link zum Volltext

Verfügbarkeit prüfen

When is the best time to transfer terminally ill cancer patients from hospitals to palliative hospice home care? Analysis of a questionnaire survey of 1,055 surviving families

Journal of clinical oncology, 2018-12, Vol.36 (34_suppl), p.61-61

2018

Link zum Volltext

Verfügbarkeit prüfen

Amphiregulin/epiregulin mRNA Expression and Primary Tumor Location in Colorectal Cancer

Anticancer research, 2019-09, Vol.39 (9), p.4729-4736

2019

Link zum Volltext

Verfügbarkeit prüfen

Osteopontin Gene Expression is Inversely Regulate 5-Fluorouracil Drug Resistance in Colon Cancer

Cancer research journal (New York, N.Y. Print), 2015, Vol.3 (2), p.42

Nakajima, Go

2015

Link zum Volltext

Verfügbarkeit prüfen

A Case of Pathologically Complete Response After Nivolumab Combined with Chemotherapy in a Gastric Cancer Patient with Virchow's Lymph Node Metastasis

Clinical and experimental gastroenterology, 2023-07, Vol.16, p.107-115

2023

Link zum Volltext

Verfügbarkeit prüfen

ERCC1 mRNA Expression as a Postoperative Prognostic Marker in Extrahepatic Bile Duct Cancer

Annals of surgical oncology, 2014-12, Vol.21 (Suppl 4), p.627-633

2014

Link zum Volltext

Verfügbarkeit prüfen

Abstract 779: Osteopontin gene expression is associated with 5-fluorouracil drug resistance in colon cancer

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.779-779

2014

Link zum Volltext

Verfügbarkeit prüfen

Elevated levels of mRNAs encoding dihydropyrimidine dehydrogenase and thymidylate synthase are associated with improved survival of patients with hepatocellular carcinoma treated with S-1

Oncology letters, 2017-07, Vol.14 (1), p.930-936

2017

Link zum Volltext

Verfügbarkeit prüfen

A Case of Abdominal Fullness Caused by a Retroperitoneal Bulky Tumor Treated with Epidural Analgesia

Gan to kagaku ryoho, 2020-11, Vol.47 (11), p.1615

2020

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of bevacizumab and irinotecan as second-line therapy for patients with metastatic colorectal cancer previously treated with fluoropyrimidines, oxaliplatin, and bevacizumab

Cancer chemotherapy and pharmacology, 2017-03, Vol.79 (3), p.579-585

2017

Link zum Volltext

Verfügbarkeit prüfen

ERCC1 codon 118 polymorphism is a useful prognostic marker in patients with pancreatic cancer treated with platinum-based chemotherapy

International journal of oncology, 2008-05, Vol.32 (5), p.1091-1096

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 264

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(212)
Mit Volltextzugriff
(243)

Publikationsform

Artikel
(258)
Berichte
(6)

Sprache

Englisch
(232)
Japanisch
(102)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Systematic analysis of microRNA expression of RNA extracted from fresh frozen and formalin-fixed paraffin-embedded samples

PTEN mRNA expression is less pronounced in left- than right-sided colon cancer: a retrospective observational study

Amphiregulin and Epiregulin mRNA expression in primary colorectal cancer and corresponding liver metastases

Impact of chronological age on efficacy and safety of fluoropyrimidine plus bevacizumab in older non-frail patients with metastatic colorectal cancer: a combined analysis of individual data from two phase II studies of patients aged >75 years

Abstract 1799: MicroRNA hsa-miR-26a expression in hepatocellular carcinoma correlates with patient survival

Enhancement of 5-fluorouracil-induced cytotoxicity by leucovorin in 5-fluorouracil-resistant gastric cancer cells with upregulated expression of thymidylate synthase

Abstract 5414: The correlation between the expression of microRNA hsa-miR-101 and the prognosis of the patient with hepatocellular carcinoma

Degraded DNA may induce discordance of KRAS status between primary colorectal cancer and corresponding liver metastases

Abstract 4444: MicroRNA hsa-miR-145 expression in hepatocellular carcinoma correlates with patient survival

Drug monitoring during FOLFOX6 therapy in a rectal cancer patient on chronic hemodialysis

Simple index for validity of the evaluation point for dosimetric verification results of intensity-modulated radiation therapy using a Farmer-type ionization chamber

Association of insulin-like growth factor binding protein-3 expression with melanoma progression

When should anti-cancer treatment be ended? Why and when to discontinue palliative chemotherapy

Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are Associated with Chemoresponse to S-1 in Colon Cancer

Multi-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancer

When is the best time to transfer terminally ill cancer patients from hospitals to palliative hospice home care? Analysis of a questionnaire survey of 1,055 surviving families

Amphiregulin/epiregulin mRNA Expression and Primary Tumor Location in Colorectal Cancer

Osteopontin Gene Expression is Inversely Regulate 5-Fluorouracil Drug Resistance in Colon Cancer

A Case of Pathologically Complete Response After Nivolumab Combined with Chemotherapy in a Gastric Cancer Patient with Virchow's Lymph Node Metastasis

ERCC1 mRNA Expression as a Postoperative Prognostic Marker in Extrahepatic Bile Duct Cancer

Abstract 779: Osteopontin gene expression is associated with 5-fluorouracil drug resistance in colon cancer

Elevated levels of mRNAs encoding dihydropyrimidine dehydrogenase and thymidylate synthase are associated with improved survival of patients with hepatocellular carcinoma treated with S-1

A Case of Abdominal Fullness Caused by a Retroperitoneal Bulky Tumor Treated with Epidural Analgesia

Phase II study of bevacizumab and irinotecan as second-line therapy for patients with metastatic colorectal cancer previously treated with fluoropyrimidines, oxaliplatin, and bevacizumab

ERCC1 codon 118 polymorphism is a useful prognostic marker in patients with pancreatic cancer treated with platinum-based chemotherapy

Suchergebnisse filtern